Treatment Action Group (TAG) Profile picture
Sep 29, 2022 9 tweets 4 min read Read on X
As new #pandemictreaty negotiations continue @WHO, TAG has partnered with @StrategicUnito to urge that the new international instrument explicitly incorporate the universal human right to benefit from scientific progress and its applications as a central framework. 🧵
Why do we believe the #RightToScience - enshrined in Article 15 of the International Covenant on Economic, Social and Cultural Rights - must be foundational to the new international instrument of pandemic preparedness and response?
1. The #RightToScience compels states to take action to end not only future pandemics, but also the pandemics of today - such as HIV, TB, HCV + antimicrobial resistance.
2. An international instrument rooted in the #RightToScience would assert that people affected by a pandemic must be involved at every stage of the scientific response - from research to clinical trial design to the development of evidence-based policy guidelines.
3. It would explicitly lay out that the #RightToScience must entail access to knowledge and information, as well as material results of scientific advancement, including medicines, vaccines + diagnostics. Image
4. It would set forth obligations on the part of member states to ensure the availability, affordability and accessibility of all scientific goods for all who need them. Image
5. It would impose an obligation for member states to cooperate on matters of health and science, rather than compete.
6. The #RightToScience establishes the primacy of human rights over intellectual property protections, demanding the prioritization of equitable distribution of scientific products over private profits. Image
Throughout the #pandemictreaty negotiation process, TAG has engaged the INB to urge a global recommitment to the human #RightToScience. You can read our submitted statements here: treatmentactiongroup.org/letter/tag-sub…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Treatment Action Group (TAG)

Treatment Action Group (TAG) Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @TAGTeam_Tweets

Oct 22, 2020
We are starting!

Are you ready? #CommunityConnect waits for you!
Tuit.cat/5ivrh
Dr. Payam Nahid explains the design of the trial:
#S31TB was a three-arm trial of:
2HPZE/2HP (4 months)
2HPZM/2HPM (4 months)
2HRZE/4HR (6 months) – control arm

It was open label, because with rifampicin is better to take without food whereas rifapentine is better with food🥑
Dorothy Namutamba answers about the collaboration communities- researchers.

One of community requests was to lower CD4 count limit to 100 for #PLWHIV to ensure we had enough data for this group.

Also, adolescents were included.

This ensures no delays in guidelines!
Read 19 tweets
Oct 21, 2020
About to start the session about the study that shows that High-dose rifapentine with moxifloxacin can shorten treatment time by a third for people with pulmonary #TB #UnionConf Image
📣 The #s31tb session starts!

#s31tb is the largest drug-sensitive #tb treatment trial in decades. It tested two arms vs. control aiming to shorten treatment to 4 months:
👉🏽substituting rifampicin with high-dose of rifapentine, &
👉🏽same + ethambutol for moxifloxacin ImageImage
🧫Innovation: the #S31TB enrolled 2,500 participants in 13 countries and included adolescents over 12, people living with HIV and people with cavitary #TB.

🤝Collaboration! #S31TB was an effort by two US-funded research networks: TBTC (at @CDC_TB) and @ACTGNetwork (at @NIH) Image
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(